(AFP) The first large-scale clinical trial of a cannabis derivative known
as cannabidiol shows it was able to cut the frequency of severe
epileptic seizures by 39 percent, researchers said Wednesday.
Cannabidiol, or CBD, is derived from cannabis plants, but does not cause users to get high.
The study in the New England Journal of Medicine comes after years of anecdotal evidence of cannabidiol’s effects.
It focused on young patients with Dravet syndrome, a rare form of epilepsy.
“Cannabidiol should not be viewed as a panacea for epilepsy, but for
patients with especially severe forms who have not responded to numerous
medications, these results provide hope that we may soon have another
treatment option,” said lead investigator Orrin Devinsky, professor of
neurology, neurosurgery, and psychiatry at New York University Langone
“We still need more research, but this new trial provides more
evidence than we have ever had of cannabidiol’s effectiveness as a
... read more at: https://www.wort.lu/en/lifestyle/new-study-cannabis-extract-cuts-seizures-for-epilepsy-patients-5928245ba5e74263e13c0796